Cancer News

Childhood cancer survivors lack a balanced diet

Childhood cancer survivors tend to have a poor diet during their adult life. This can lead to a higher risk of developing serious illnesses.

New combination-treatment for advanced soft tissue sarcoma

The FDA granted approval to olaratumab with doxorubicin combination treatment for patients with advanced soft tissue sarcoma (STS).

Short-term training improves aerobic performance in lung cancer

High-intensity interval training (HIIT) in patients with resectable non-small cell lung cancer (NSCLC) before surgey improves aerobic performance.

Atezolizumab got approved for non-small cell lung cancer

FDA approved atezolizumab treatment for non-small cell lung cancer (NSCLC) patients whose disease progressed during or following platinum-containing chemotherapy.

Chemotherapy with topotecan deals better with retinoblastoma

Topotecan-based triple-drug chemotherapy as a first line therapy can be used for patients with retinoblastoma.

Common prostate cancer treatment linked to dementia

Prostate cancer patients treated with testosterone-lowering drugs are more likely to develop dementia.

Bowel cancer patients need emotional and practical support

Bowel cancer patients with no psychological support after surgery, struggle with depression and poor well-being.

Ribociclib increases progression-free survival in breast cancer

Ribociclib (CDK4/6 inhibitor) combined with letrozole improves by 44% the progression-free survival in postmenopausal women with hormone receptor positive advanced breast cancer.

Nintedanib improves progression-free survival in metastatic colorectal cancer

Nintedanib (a multiple tyrosine kinase inhibitor) improves progression-free survival (PFS) in metastatic colorectal cancer.

Niraparib improves outcomes in patients with ovarian cancer

The PARP inhibitor niraparib improves primary and secondary endpoints in platinum-sensitive recurrent ovarian cancer. Survival was significantly improved.

Nivolumab prolongs survival with less side effects in head and neck cancer

Nivolumab prolongs overall survival and reduces side effects in patients with relapsed metastatic head and neck cancer.

Adjuvant therapy with ipilimumab may improve survival in melanoma

Overall survival in patients with stage 3 melanoma can be significantly increased with ipilimumab as adjuvant therapy.

Sunitinib increases disease-free survival in renal cell carcinoma

Sunitinib can increase disease-free survival as adjuvant treatment for renal cell carcinoma after nephrectomy.

Checkpoint inhibitors benefit survival in non-small-cell lung cancer

Atezolizumab, can prolong survival rate in patients with non-small-cell lung cancer regardless their PD-L1 expression.

A specific estrogen receptor prolongs survival in breast cancer

Fulvestrant increases progression-free survival (PFS) in hormone receptor positive (ER+) advanced breast cancer patients.

New treatment option for patients with advanced lung cancer

Pembrolizumab can be the alternative option for first line treatment of patients with advanced lung cancer and high PD-L1 expression.

Immunotherapy: a therapeutic alternative for bladder cancer

Immune check point inhibitors seem to be the suitable treatment for chemotherapy-ineligible patients with metastatic bladder cancer.

Breast reconstruction right after mastectomy improves psychology

Immediate breast reconstruction (IBR) after mastectomy causes fewer breast cancer psychological side-effects, compared to delayed breast reconstruction (DBR).

Advanced radiotherapy better tolerated in cervical and endometrial cancer

Intensity-modulated radiation therapy (IMRT) causes less side effects in cervical and endometrial cancer than conventional radiotherapy (RT).

Brachytherapy alone causes less side-effects in mid-risk prostate cancer

Brachytherapy alone can give similar results & fewer side-effects in mid-risk prostate cancer compared to its combination with external beam therapy (EBT).

Innovative alternative to mastectomy in recurrent breast cancer

Treating recurrent breast cancer with a 2nd lumpectomy and partial breast irradiation brings better results compared to conventional breast surgery.

Chemotherapy seems helpful in patients with follicular lymphoma

Chemotherapy following radiotherapy can improve progression-free survival (PFS) in patients with follicular lymphoma.

Stereotactic radiotherapy against recurrent head and neck cancer

Stereotactic radiation therapy used in patients with recurrent head and neck cancer can cause fewer side effects than traditional treatments.

Chemoradiation benefits postoperative patients with medulloblastoma.

Chemotherapy and radiation after surgery improves survival in adult patients with medulloblastoma.

Multiple myeloma treatment expected to be approved in Europe

European regulators have adopted a positive opinion for ixazomib capsules combined with lenalidomide and dexamethasone for the treatment of multiple myeloma.

Intense radiation scheme can help non-small cell lung cancer patients

Hypo-fractionated radiation has similar outcomes with conventional one for non-small lung cancer patients and milder side-effects, despite its shorter duration.

Stereotactic radiosurgery: a new weapon against brain metastases

Stereotactic radiosurgery has shown better results in survival, less cognitive decline and better quality of life compared to whole brain radiotherapy.

Additional radiation decreases recurrence rate of ductal carcinoma

A supplemental "boost" of radiation may reduce breast cancer recurrence in Ductal Carcinoma in Situ (DCIS) patients.

Surgery with targeted therapy benefits metastatic renal cancer patients

Cytoreductive surgery with targeted therapy improves survival rates in metastatic renal cell cancer patients.

Accelerated radiotherapy equivalent to conventional for prostate cancer

Oncology trials show similar outcomes and side effects for early stage prostate cancer with conventional and hypo-fractionated radiotherapy.

Login to your account

Did you forget your password?